MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model.
Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California, San Francisco, USA.
Karl
K
Turetschek
Anda
A
Preda
Eugenia
E
Floyd
David M
DM
Shames
Viktor
V
Novikov
Timothy P L
TP
Roberts
Jeanette M
JM
Wood
Yanjun
Y
Fu
Wayne O
WO
Carter
Robert C
RC
Brasch
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D003287:Contrast Media; D003911:Dextrans; D016228:Endothelial Growth Factors; D005260:Female; D052203:Ferrosoferric Oxide; D019786:Gadolinium DTPA; D036341:Intercellular Signaling Peptides and Proteins; D007501:Iron; D008222:Lymphokines; D046911:Macromolecular Substances; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D010087:Oxides; D010793:Phthalazines / Q000494:pharmacology*; D011725:Pyridines; D014407:Tumor Cells, Cultured; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D003287:Contrast Media; D003911:Dextrans; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D046911:Macromolecular Substances; D058185:Magnetite Nanoparticles; D010087:Oxides; D010793:Phthalazines; D011725:Pyridines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C404768:vatalanib; D007501:Iron; C065507:ferumoxides; D019786:Gadolinium DTPA; D052203:Ferrosoferric Oxide